0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Time Lag Bias in Publishing Clinical Trials—Reply

John P. A. Ioannidis, MD
JAMA. 1998;279(24):1952-1953. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-24-jac80011.
Text Size: A A A
Published online

Extract

In Reply.—Publication bias and time lag bias are distinct terms with complementary implications. One may exist in the absence of the other, for example, when negative trials take longer to complete (eg, due to lower event rates, smaller treatment effects, or both), even if subsequently published as quickly as positive ones. Another example is when, looking retrospectively, all trials on a subject have been published, but negative ones were delayed in the process. As Drs Clarke and Stewart highlight, we could be misled if meta-analyses (and medical decisions) are based on early appearing evidence misrepresenting the true treatment effects. Unfortunately, considering only evidence from trials that started before a certain date may be a suboptimal solution because it means disregarding the latest evidence, which may be most pertinent to current practice. In fields with rapid new drug development, the marketing honeymoon of drugs is short before being ousted by newer agents. Delays of 2 to 3 years (and occasionally longer) for negative trials in such fields can largely mislead practice, while meta-analyses excluding recent evidence to escape bias or waiting 20 years to be all-inclusive run the risk of becoming archaeological exercises. I fully agree with Clarke and Stewart that we need more research on the impact of time lag bias, and efforts should be prospective.1,2 Empirical prospective evaluations in continuous updating initiatives, such as the Cochrane Collaboration,3 may offer more solid evidence on how reported treatment effects for various treatments may change over time and may offer hints on how to anticipate and dissect such heterogeneity.1 The problem of time lag bias only heightens the importance of careful meta-analysis efforts, such as those led by the Cochrane Collaboration.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();